Combination therapy in dyslipidaemia – A practical approach
Professor Frederick Raal and Dr Zaheer Bayat consider a practical approach to optimal lipid-lowering therapy for patients who are at high or very high risk of atherosclerotic cardiovascular disease (ASCVD)
Learning objectives
- How to assess cardiovascular risk and determine the low-density lipoprotein cholesterol (LDL-c) treatment goal for each patient based on their risk
- To understand the safety and efficacy of different pharmacological lipid-lowering therapies, how to sequence these treatments, and the benefits of an early and aggressive lipid-lowering strategy
- The benefits of combination statin-ezetimibe therapy, particularly as first-line treatment for patients at high or very high cardiovascular risk.
To access this module, please register or login:
